Ignite Creation Date:
2024-05-06 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02752295
Status:
COMPLETED
Last Update Posted:
2016-09-16
First Post:
2016-04-07
Brief Title:
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Study Overview
Official Title:
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ISCIW
Brief Summary:
This study intents to determine who will benefit from an intensive brief stress coping intervention week ISCIW as secondary prevention for real world affective disorder patients
Detailed Description:
Affective disorders are associated with a substantial personal and socio-economic burden This study evaluates an intensive brief stress-coping intervention week ISCIW as feasible follow-up treatment for real world patients who suffer from this highly prevalent and chronic stress-related disorders Stress-associated blood Interleukin-6 Homocystein Myeloperoxidase saliva cortisol and psychosocial screening parameters will be analyzed to determine who will benefit from the ISCIW All patients were identified in a preventive medical screening before pre-treatment for at least three month as outpatient and the following inclusion to the follow-up ISCIW-trial at the Health and Prevention Center Sanatorium Hera Vienna Austria For the three planed groups and interventions see interventions and arms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None